| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 2320-2327, Copyright © 1989 by Endocrine Society
ARTICLES |
L Bassas, M Girbau, MA Lesniak, J Roth and F de Pablo
Servicio de Endocrinologia, Hospital de la Santa Cruz y San Pablo, Barcelona, Spain.
In whole brain of chick embryos insulin receptors are highest at the end of embryonic development, while insulin-like growth factor-I (IGF- I) receptors dominate in the early stages. These studies provided evidence for developmental regulation of both types of receptors, but they did not provide information on possible differences between brain regions at each developmental stage or within one region at different embryonic ages. We have now localized the specific binding of [125I]insulin and [125I]IGF-I in sections of head and brain using autoradiography and computer-assisted densitometric analysis. Embryos have been studied from the latter part of organogenesis (days 6 and 12) through late development (day 18, i.e. 3 days before hatching), and the binding patterns have been compared with those in the adult brain. At all ages the binding of both ligands was to discrete anatomical regions. Interestingly, while in late embryos and adult brain the patterns of [125I]insulin and [125I] IGF-I binding were quite distinct, in young embryos both ligands showed very similar localization of binding. In young embryos the retina and lateral wall of the growing encephalic vesicles had the highest binding of both [125I]insulin and [125I]IGF-I. In older embryos, as in the adult brain, insulin binding was high in the paleostriatum augmentatum and molecular layer of the cerebellum, while IGF-I binding was prominent in the hippocampus and neostriatum. The mapping of receptors in a vertebrate embryo model from early prenatal development until adulthood predicts great overlap in any possible function of insulin and IGF-I in brain development, while it anticipates differential localized actions of the peptides in the mature brain.
This article has been cited by other articles:
![]() |
Y. Arsenijevic, S. Weiss, B. Schneider, and P. Aebischer Insulin-Like Growth Factor-I Is Necessary for Neural Stem Cell Proliferation and Demonstrates Distinct Actions of Epidermal Growth Factor and Fibroblast Growth Factor-2 J. Neurosci., September 15, 2001; 21(18): 7194 - 7202. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Erhardt, E. A. Fradinger, L. A. Cervini, J. E. Rivier, and N. M. Sherwood Early Expression of Pituitary Adenylate Cyclase-Activating Polypeptide and Activation of its Receptor in Chick Neuroblasts Endocrinology, April 1, 2001; 142(4): 1616 - 1625. [Abstract] [Full Text] |
||||
![]() |
M. García-de Lacoba, C. Alarcón, E. J. de la Rosa, and F. de Pablo Insulin/Insulin-Like Growth Factor-I Hybrid Receptors with High Affinity for Insulin Are Developmentally Regulated during Neurogenesis Endocrinology, January 1, 1999; 140(1): 233 - 243. [Abstract] [Full Text] |
||||
![]() |
Y. Arsenijevic and S. Weiss Insulin-Like Growth Factor-I Is a Differentiation Factor for Postmitotic CNS Stem Cell-Derived Neuronal Precursors: Distinct Actions from Those of Brain-Derived Neurotrophic Factor J. Neurosci., March 15, 1998; 18(6): 2118 - 2128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |